orandbio
Biomaterial-based medical devices for tissue and organ regeneration.
Orandbio is a biotechnology company founded in 2024 and headquartered in Uiwang, South Korea, that develops medical devices and regenerative therapies based on advanced biomaterials. The company, led by CEO Dong Keun Han, focuses on creating convergent medical products, including tissue engineering solutions and pharmaceuticals. Orandbio utilizes core technologies such as biomaterial molding, anti-inflammatory biodegradable polymers, bioactive particle processing, and bio-functional scaffolds to treat damaged tissues and organs.
The company's product pipeline targets critical areas like kidney recovery, joint repair, bone and periodontal regeneration, and ovarian function restoration. Its flagship product, CharmRenal, is being developed to restore kidney function in patients with chronic kidney disease, potentially preventing the need for dialysis. Another key product, CharmCarti, aims to treat moderate to severe osteoarthritis by reducing joint friction and promoting cartilage regeneration. Further products include CharmOss, a high-performance bone graft, and CharmGuide, a periodontal tissue regenerative scaffold.
In April 2025, Orandbio announced the development of a novel anti-inflammatory and antioxidant scaffold that successfully restored ovarian function in animal studies, with the research published in *Advanced Healthcare Materials*. The company has secured investment from accelerator Genaxis and plans to initiate preclinical trials for its main products by 2026. Orandbio anticipates regulatory approval and market release for its bone graft and periodontal scaffold products in 2027, with a business model focused on developing and commercializing these specialized therapeutic devices for the global healthcare market.
Keywords: regenerative medicine, biomaterials, tissue engineering, medical devices, therapeutic devices, organ regeneration, kidney disease treatment, osteoarthritis therapy, bone graft, periodontal regeneration, anti-inflammatory polymers, bio-functional scaffolds, CharmRenal, CharmCarti, biotechnology, Dong Keun Han, South Korea biotech, ovarian function restoration, cartilage regeneration, chronic kidney disease